EMT/MET PRELP cell–cell adhesion dysplasia retinoblastoma

Journal

Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829

Informations de publication

Date de publication:
08 Oct 2022
Historique:
received: 25 06 2022
revised: 14 08 2022
accepted: 23 08 2022
entrez: 14 10 2022
pubmed: 15 10 2022
medline: 15 10 2022
Statut: epublish

Résumé

Retinoblastoma (RB) is the most common intraocular pediatric cancer. Nearly all cases of RB are associated with mutations compromising the function of the

Identifiants

pubmed: 36230849
pii: cancers14194926
doi: 10.3390/cancers14194926
pmc: PMC9563430
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : Fight for Sight
ID : 5081/5082, 1582/1583
Organisme : Childhood Eye Cancer Trust
ID : 23 Jul 2018 and 13 Oct 2021
Organisme : Santen (Japan)
ID : 5 Apr 2018
Organisme : Medical Research Council
ID : MR/K501268/1
Pays : United Kingdom
Organisme : Moorfields Eye Charity
ID : R150036A/GR000113

Références

Clin Transl Med. 2017 Nov 9;6(1):42
pubmed: 29124525
Dev Growth Differ. 2012 Apr;54(3):327-40
pubmed: 22524604
Cytokine. 2012 Jul;59(1):100-7
pubmed: 22534113
Matrix Biol. 2019 Jan;75-76:271-285
pubmed: 29253518
Mol Vis. 2006 Sep 13;12:1057-66
pubmed: 17093390
Cell. 2016 Aug 25;166(5):1308-1323.e30
pubmed: 27565351
Nat Rev Neurosci. 2014 Jul;15(7):431-42
pubmed: 24894585
J Biol Chem. 2021 Jan-Jun;296:100278
pubmed: 33428936
Gene Ther. 2017 Jul;24(7):399-407
pubmed: 28485721
Dev Cell. 2013 Jul 15;26(1):31-44
pubmed: 23792146
Retina. 2000;20(2):176-83
pubmed: 10783951
Lancet Oncol. 2013 Apr;14(4):270-1
pubmed: 23498720
Tumour Biol. 2016 Feb;37(2):1461-9
pubmed: 26662307
Mol Oncol. 2007 Jun;1(1):84-96
pubmed: 18516279
Glia. 2003 Jul;43(1):70-76
pubmed: 12761869
PLoS Genet. 2010 Apr 22;6(4):e1000923
pubmed: 20421947
Cell. 2011 Mar 4;144(5):646-74
pubmed: 21376230
J Biol Chem. 2010 Dec 31;285(53):42075-85
pubmed: 20974860
Oncogene. 2018 Mar;37(12):1551-1560
pubmed: 29321667
BMC Genomics. 2020 Jun 3;21(1):384
pubmed: 32493350
Exp Cell Res. 2017 Oct 15;359(2):299-311
pubmed: 28844885
Cancers (Basel). 2020 Nov 13;12(11):
pubmed: 33202923
Oncogene. 2009 Aug 6;28(31):2796-805
pubmed: 19483725
Nature. 1986 Oct 16-22;323(6089):643-6
pubmed: 2877398
Genes Dev. 2004 Jul 15;18(14):1681-94
pubmed: 15231717
PLoS One. 2017 May 9;12(5):e0177337
pubmed: 28486560
Nat Commun. 2021 Jul 27;12(1):4535
pubmed: 34315877
Genes Chromosomes Cancer. 2005 Jul;43(3):294-301
pubmed: 15834944
J Clin Invest. 2017 Mar 1;127(3):888-898
pubmed: 28165337
Brain Behav Immun. 2014 Aug;40:252-68
pubmed: 24607660
Cell. 1999 Jul 23;98(2):137-46
pubmed: 10428026
Prog Retin Eye Res. 2006 May;25(3):277-95
pubmed: 16515881
Mol Cell Oncol. 2015 Feb 25;2(3):e975645
pubmed: 27308453
Genes Dev. 1998 Jun 1;12(11):1599-609
pubmed: 9620848
Cell Res. 2009 Feb;19(2):156-72
pubmed: 19153598
World J Gastroenterol. 2020 Sep 21;26(35):5328-5342
pubmed: 32994691
PLoS One. 2010 Jul 26;5(7):e11774
pubmed: 20668675
J Biol Chem. 2002 Apr 26;277(17):15061-8
pubmed: 11847210
Front Biosci (Landmark Ed). 2010 Jan 01;15(1):359-72
pubmed: 20036825
Nat Rev Cancer. 2002 Jun;2(6):442-54
pubmed: 12189386
Science. 2017 Jul 21;357(6348):
pubmed: 28729483
BMC Genomics. 2007 Apr 11;8:98
pubmed: 17425807
J Clin Med. 2019 Jan 27;8(2):
pubmed: 30691241
Genome Biol. 2016 Apr 27;17:75
pubmed: 27122128
Small GTPases. 2019 Sep;10(5):388-394
pubmed: 28657426
Nan Fang Yi Ke Da Xue Xue Bao. 2015 Nov;35(11):1564-9
pubmed: 26607076
J Cell Biol. 2015 Sep 28;210(7):1075-83
pubmed: 26416961
Cell Div. 2008 May 19;3:9
pubmed: 18489754
BMC Cancer. 2017 Jun 20;17(1):434
pubmed: 28633655
Dis Model Mech. 2018 Jun 15;11(6):
pubmed: 29914980
Cancers (Basel). 2021 Feb 11;13(4):
pubmed: 33670346
Sci Rep. 2019 Jan 24;9(1):673
pubmed: 30679596

Auteurs

Jack Hopkins (J)

UCL Institute of Ophthalmology, University College London, London EC1V 9EL, UK.

Ken Asada (K)

Cancer Translational Research Team, RIKEN Center for Advanced Intelligence Project, Tokyo 103-0027, Japan.
Division of Medical AI Research and Development, National Cancer Center Research Institute, Tokyo 104-0045, Japan.

Alex Leung (A)

UCL Institute of Ophthalmology, University College London, London EC1V 9EL, UK.

Vasiliki Papadaki (V)

UCL Institute of Ophthalmology, University College London, London EC1V 9EL, UK.

Hongorzul Davaapil (H)

UCL Institute of Ophthalmology, University College London, London EC1V 9EL, UK.

Matthew Morrison (M)

UCL Institute of Ophthalmology, University College London, London EC1V 9EL, UK.

Tomoko Orita (T)

UCL Institute of Ophthalmology, University College London, London EC1V 9EL, UK.
Department of Ophthalmology, Yamaguchi University Graduate School of Medicine, Yamaguchi 755-8505, Japan.

Ryohei Sekido (R)

UCL Institute of Ophthalmology, University College London, London EC1V 9EL, UK.

Hirofumi Kosuge (H)

School of Engineering, The University of Tokyo, Tokyo 113-8656, Japan.

M Ashwin Reddy (MA)

Retinoblastoma Unit, Barts Health NHS Trust, Royal London Hospital, London E1 1BB, UK.
Retinoblastoma Service, Barts Health Trust, Royal London Hospital, London E1 1FR, UK.

Kazuhiro Kimura (K)

Department of Ophthalmology, Yamaguchi University Graduate School of Medicine, Yamaguchi 755-8505, Japan.

Akihisa Mitani (A)

Department of Respiratory Medicine, Graduate School of Medicine, The University of Tokyo, Tokyo 113-0033, Japan.

Kouhei Tsumoto (K)

School of Engineering, The University of Tokyo, Tokyo 113-8656, Japan.
Institute of Medical Science, The University of Tokyo, Tokyo 108-8639, Japan.

Ryuji Hamamoto (R)

Cancer Translational Research Team, RIKEN Center for Advanced Intelligence Project, Tokyo 103-0027, Japan.
Division of Medical AI Research and Development, National Cancer Center Research Institute, Tokyo 104-0045, Japan.

Mandeep S Sagoo (MS)

UCL Institute of Ophthalmology, University College London, London EC1V 9EL, UK.
Retinoblastoma Unit, Barts Health NHS Trust, Royal London Hospital, London E1 1BB, UK.
NIHR, Biomedical Research Centre for Ophthalmology Moorfields Eye Hospital, London EC1V 2PD, UK.

Shin-Ichi Ohnuma (SI)

UCL Institute of Ophthalmology, University College London, London EC1V 9EL, UK.

Classifications MeSH